{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:34:34Z","timestamp":1785443674328,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIAID, NIH","award":["R01AI148357-01"],"award-info":[{"award-number":["R01AI148357-01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Clostridioides difficile<\/jats:italic> (<jats:italic>C. difficile<\/jats:italic>) is a gram-positive, spore-forming, anaerobic bacterium known to be the most common cause of hospital-acquired and antibiotic-associated diarrhea. <jats:italic>C. difficile<\/jats:italic> infection rates are on the rise worldwide and treatment options are limited, indicating a clear need for novel therapeutics. Gnotobiotic piglets are an excellent model to reproduce the acute pseudomembranous colitis (PMC) caused by <jats:italic>C. difficile<\/jats:italic> due to their physiological similarities to humans and high susceptibility to infection. Here, we established a gnotobiotic pig model of <jats:italic>C. difficile<\/jats:italic> infection and disease using a hypervirulent strain. <jats:italic>C. difficile<\/jats:italic>-infected pigs displayed classic signs of <jats:italic>C. difficile<\/jats:italic> infection, including severe diarrhea and weight loss. Inoculated pigs had severe gross and microscopic intestinal lesions. <jats:italic>C. difficile<\/jats:italic> infection caused an increase in pro-inflammatory cytokines in samples of serum, large intestinal contents, and pleural effusion. <jats:italic>C. difficile<\/jats:italic> spores and toxins were detected in the feces of inoculated animals as tested by anaerobic culture and cytotoxicity assays. Successful establishment of this model is key for future work as therapeutics can be evaluated in an environment that accurately mimics what happens in humans. The model is especially suitable for evaluating potential prophylactics and therapeutics, including vaccines and passive immune strategies.<\/jats:p>","DOI":"10.1186\/s13099-022-00496-y","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T09:47:09Z","timestamp":1654508829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Establishment of a gnotobiotic pig model of Clostridioides difficile infection and disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Charlotte","family":"Nyblade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Parreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Oakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan M.","family":"Mahsoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongrong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"issue":"7","key":"496_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10096-019-03539-6","volume":"38","author":"J Czepiel","year":"2019","unstructured":"Czepiel J, Dr\u00f3\u017cd\u017c M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect. 2019;38(7):1211\u201321.","journal-title":"Eur J Clin Microbiol Infect"},{"issue":"3","key":"496_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/649799","volume":"201","author":"J Steele","year":"2010","unstructured":"Steele J, Feng H, Parry N, Tzipori S. Piglet models of acute or chronic Clostridium difficile illness. J Infect Dis. 2010;201(3):428\u201334.","journal-title":"J Infect Dis"},{"issue":"8","key":"496_CR3","doi-asserted-by":"publisher","first-page":"e00037","DOI":"10.1128\/CVI.00037-17","volume":"24","author":"H Yu","year":"2017","unstructured":"Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, et al. Cytokines are markers of the Clostridium difficile-induced inflammatory response and predict disease severity. Clin Vaccine Immunol. 2017;24(8):e00037-e117.","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"496_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/femsre\/fux048","volume":"41","author":"R Chandrasekaran","year":"2017","unstructured":"Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41(6):723\u201350.","journal-title":"FEMS Microbiol Rev"},{"issue":"4","key":"496_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124235","volume":"10","author":"H Yu","year":"2015","unstructured":"Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, et al. Identification of toxemia in patients with Clostridium difficile infection. PLoS ONE. 2015;10(4): e0124235.","journal-title":"PLoS ONE"},{"issue":"3","key":"496_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/infdis\/jir748","volume":"205","author":"J Steele","year":"2012","unstructured":"Steele J, Chen K, Sun X, Zhang Y, Wang H, Tzipori S, et al. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. J Infect Dis. 2012;205(3):384\u201391.","journal-title":"J Infect Dis"},{"issue":"48","key":"496_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.anaerobe.2017.10.006","volume":"1","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Yang Z, Gao S, Hamza T, Yfantis HG, Lipsky M, et al. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model. Anaerobe. 2017;1(48):249\u201356.","journal-title":"Anaerobe"},{"issue":"3","key":"496_CR8","doi-asserted-by":"publisher","first-page":"e00551","DOI":"10.1128\/mBio.00551-15","volume":"6","author":"GP Carter","year":"2015","unstructured":"Carter GP, Chakravorty A, Nguyen TAP, Mileto S, Schreiber F, Li L, et al. Defining the roles of TcdA and TcdB in localized gastrointestinal disease, systemic organ damage, and the host response during Clostridium difficile infections. MBio. 2015;6(3):e00551.","journal-title":"MBio"},{"issue":"16","key":"496_CR9","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"496_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13099-021-00475-9","volume":"14","author":"M Brauer","year":"2022","unstructured":"Brauer M, Herrmann J, Z\u00fchlke D, M\u00fcller R, Riedel K, Sievers S. Myxopyronin B inhibits growth of a fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis. Gut Pathog. 2022;14(1):4.","journal-title":"Gut Pathog"},{"issue":"2","key":"496_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/1574-6968.12367","volume":"352","author":"ML Hutton","year":"2014","unstructured":"Hutton ML, Mackin KE, Chakravorty A, Lyras D. Small animal models for the study of Clostridium difficile disease pathogenesis. FEMS Microbiol Lett. 2014;352(2):140\u20139.","journal-title":"FEMS Microbiol Lett"},{"key":"496_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-7091-6553-9_17","volume":"12","author":"LJ Saif","year":"1996","unstructured":"Saif LJ, Ward LA, Yuan L, Rosen BI, To TL. The gnotobiotic piglet as a model for studies of disease pathogenesis and immunity to human rotaviruses. Arch Virol Suppl. 1996;12:153\u201361.","journal-title":"Arch Virol Suppl"},{"key":"496_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/B978-0-12-804561-9.00005-0","volume-title":"Gnotobiotics","author":"L Yuan","year":"2017","unstructured":"Yuan L, Jobst PM, Weiss M. Chapter 5\u2014Gnotobiotic pigs: from establishing facility to modeling human infectious diseases. In: Schoeb TR, Eaton KA, editors. Gnotobiotics. London: Academic Press; 2017. p. 349\u201368."},{"issue":"7","key":"496_CR14","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1128\/IAI.01336-10","volume":"79","author":"X Sun","year":"2011","unstructured":"Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H. Mouse relapse model of Clostridium difficile infection. Infect Immun. 2011;79(7):2856\u201364.","journal-title":"Infect Immun"},{"issue":"7","key":"496_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.cmi.2019.10.023","volume":"26","author":"SC Lim","year":"2020","unstructured":"Lim SC, Knight DR, Riley TV. Clostridium difficile and one health. Clin Microbiol Infect. 2020;26(7):857\u201363.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"496_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1177\/104063870501700602","volume":"17","author":"JG Songer","year":"2005","unstructured":"Songer JG, Uzal FA. Clostridial enteric infections in pigs. J Vet Diagn Invest. 2005;17(6):528\u201336.","journal-title":"J Vet Diagn Invest"},{"key":"496_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00215-12","author":"H Wang","year":"2012","unstructured":"Wang H, Sun X, Zhang Y, Li S, Chen K, Shi L, et al. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun. 2012. https:\/\/doi.org\/10.1128\/IAI.00215-12.","journal-title":"Infect Immun"},{"issue":"6","key":"496_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/infdis\/jiu196","volume":"210","author":"Z Yang","year":"2014","unstructured":"Yang Z, Schmidt D, Liu W, Li S, Shi L, Sheng J, et al. A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice. J Infect Dis. 2014;210(6):964\u201372.","journal-title":"J Infect Dis"},{"issue":"567","key":"496_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4905","volume":"12","author":"K Chen","year":"2020","unstructured":"Chen K, Zhu Y, Zhang Y, Hamza T, Yu H, Fleur AS, et al. A probiotic yeast-based immunotherapy against Clostridioides difficile infection. Sci Transl Med. 2020;12(567): eaax4905.","journal-title":"Sci Transl Med."},{"issue":"3","key":"496_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1128\/CMR.00082-09","volume":"23","author":"J Freeman","year":"2010","unstructured":"Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529\u201349.","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"496_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cmi.2017.11.011","volume":"24","author":"SE Giancola","year":"2018","unstructured":"Giancola SE, Williams RJ, Gentry CA. Prevalence of the Clostridium difficile BI\/NAP1\/027 strain across the United States veterans health administration. Clin Microbiol Infect. 2018;24(8):877\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"496_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/1469-0691.12619","volume":"20","author":"E Valiente","year":"2014","unstructured":"Valiente E, Cairns MD, Wren BW. The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move. Clin Microbiol Infect. 2014;20(5):396\u2013404.","journal-title":"Clin Microbiol Infect"},{"issue":"33","key":"496_CR23","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1016\/j.vaccine.2017.06.062","volume":"35","author":"J-H Tian","year":"2017","unstructured":"Tian J-H, Glenn G, Flyer D, Zhou B, Liu Y, Sullivan E, et al. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models. Vaccine. 2017;35(33):4079\u201387.","journal-title":"Vaccine"},{"issue":"39","key":"496_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.anaerobe.2016.02.011","volume":"1","author":"ML Kelly","year":"2016","unstructured":"Kelly ML, Ng YK, Cartman ST, Collery MM, Cockayne A, Minton NP. Improving the reproducibility of the NAP1\/B1\/027 epidemic strain R20291 in the hamster model of infection. Anaerobe. 2016;1(39):51\u20133.","journal-title":"Anaerobe"},{"issue":"6","key":"496_CR25","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1053\/j.gastro.2008.09.002","volume":"135","author":"X Chen","year":"2008","unstructured":"Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, et al. A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008;135(6):1984\u201392.","journal-title":"Gastroenterology"},{"issue":"5","key":"496_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1128\/jcm.17.5.830-833.1983","volume":"17","author":"M Cooperstock","year":"1983","unstructured":"Cooperstock M, Riegle L, Woodruff CW, Onderdonk A. Influence of age, sex, and diet on asymptomatic colonization of infants with Clostridium difficile. J Clin Microbiol. 1983;17(5):830\u20133.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"496_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1128\/cdli.4.6.719-722.1997","volume":"4","author":"TS Steiner","year":"1997","unstructured":"Steiner TS, Flores CA, Pizarro TT, Guerrant RL. Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis. Clin Diagn Lab Immunol. 1997;4(6):719\u201322.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"10","key":"496_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nrmicro.2016.108","volume":"14","author":"MC Abt","year":"2016","unstructured":"Abt MC, McKenney PT, Pamer EG. Clostridium difficile colitis: pathogenesis and host defence. Nat Rev Microbiol. 2016;14(10):609\u201320.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"496_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41575-020-0350-4","volume":"18","author":"A Khoruts","year":"2021","unstructured":"Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 2021;18(1):67\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"496_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/ismej.2007.23","volume":"1","author":"X Pang","year":"2007","unstructured":"Pang X, Hua X, Yang Q, Ding D, Che C, Cui L, et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J. 2007;1(2):156\u201362.","journal-title":"ISME J"},{"issue":"9","key":"496_CR31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1128\/CVI.00730-15","volume":"23","author":"DJ Schmidt","year":"2016","unstructured":"Schmidt DJ, Beamer G, Tremblay JM, Steele JA, Kim HB, Wang Y, et al. A tetraspecific VHH-based neutralizing antibody modifies disease outcome in three animal models of Clostridium difficile infection. Clin Vaccine Immunol CVI. 2016;23(9):774\u201384.","journal-title":"Clin Vaccine Immunol CVI"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-022-00496-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-022-00496-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-022-00496-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T01:03:38Z","timestamp":1654563818000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-022-00496-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["496"],"URL":"https:\/\/doi.org\/10.1186\/s13099-022-00496-y","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All Gn pig procedures were approved by the Virginia Tech Institutional Animal Care and Use Committee (IACUC CVM 20-080).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}